Evidence-Based Medicine

Print Friendly
No Photo Provided

Rahul Mhaskar, MPH, PhD

Assistant Professor, College Of Medicine Internal Medicine

Assistant Professor, Coph Global Health

College Of Medicine Internal Medicine

Assistant Professor, Internal Medicine, University of South Florida

Contact Info 12901 Bruce B. Downs Blvd.
MDC 27
Tampa, FL 33612

Academic Email: rmhaskar@health.usf.edu

Academic Phone: (813) 974-9608

View My C.V.

Education

  • PhD, Public Health, University Of South Florida, 2010
  • PhD, Public Health, University of South Florida, 2010
  • MPH, Public Health, The University Of Arizona, 2005
  • MPH, Public Health, The University of Arizona, 2005
  • BHMS (MD), Medicine, University of Pune, 1999

Memberships

  • American Public Health Association (Member and Reviewer, 2011 - Present)

Recent Publications

  • Mhaskar, RS.Reljic, T.Wao, H.Kumar, A.Miladinovic, B.Djulbegovic, B. Treatment-related harms: what was planned and what was reported? National Cancer Institute's Co-operative group phase III randomized controlled trials: a systematic review. Journal of clinical epidemiology. 67(3) : 354-6, 2014. http://www.ncbi.nlm.nih.gov/pubmed/24055164
  • Mhaskar, R.B Bercu, B.Djulbegovic, B. At what level of collective equipoise does a randomized clinical trial become ethical for the members of institutional review board/ethical committees? Acta informatica medica : AIM : journal of the Society for Medical Informatics of Bosnia & Herzegovina : časopis Društva za medicinsku informatiku BiH. 21(3) : 156-9, 2013. http://www.ncbi.nlm.nih.gov/pubmed/24167382
  • Djulbegovic, B.Kumar, A.Miladinovic, B.Reljic, T.Galeb, S.Mhaskar, A.Mhaskar, R.Hozo, I.Tu, D.Stanton, HA.Booth, CM.Meyer, RM. Treatment success in cancer: industry compared to publicly sponsored randomized controlled trials. PloS one. 8(3) : e58711, 2013. http://www.ncbi.nlm.nih.gov/pubmed/23555593
  • Miladinovic, B.Mhaskar, R.Hozo, I.Kumar, A.Mahony, H.Djulbegovic, B. Optimal information size in trial sequential analysis of time-to-event outcomes reveals potentially inconclusive results because of the risk of random error. Journal of clinical epidemiology. 66(6) : 654-9, 2013. http://www.ncbi.nlm.nih.gov/pubmed/23403248
  • Tea Reljic, Ambuj Kumar, Helen Mahoney, Branko Miladinovic, Mohamed A Kharfan-Dabaja, Rahul Mhaskar, Benjamin Djulbegovic Efficacy Of Novel Agents As Maintenance Therapy For Multiple Myeloma: A Direct and Network Meta-Analysis ASH 2013 Annual Meeting Abstract. (194) , 2013.
  • Dariam Cardentey Oliva, Jose M. Soto, Hesborn Wao, Clement K. Gwede, Rahul Mhaskar Awareness of ongoing clinical trial information: physicians’ and clinical trial administrators’ perspectives Sixth AACR Conference on The Science of Cancer Health Disparities in Racial/Ethnic Minorities and the Medically Underserved. , 2013.
  • Mhaskar, R.Alandikar, V.Emmanuel, P.Djulbegovic, B.Patel, S.Patel, A.Naik, E.Mohapatra, S.Kumar, A. Adherence to antiretroviral therapy in India: a systematic review and meta-analysis. Indian journal of community medicine : official publication of Indian Association of Preventive & Social Medicine. 38(2) : 74-82, 2013. http://www.ncbi.nlm.nih.gov/pubmed/23878418
  • Mhaskar, RS.Ricardo, I.Azliyati, A.Laxminarayan, R.Amol, B.Santosh, W.Boo, K. Assessment of risk factors of helicobacter pylori infection and peptic ulcer disease. Journal of global infectious diseases. 5(2) : 60-7, 2013. http://www.ncbi.nlm.nih.gov/pubmed/23853433
  • Branko Miladinovic, Rahul Mhaskar, Ambuj Kumar, Sehwan Kim, Ronald Schonwetter, and Benjamin Djulbegovic External Validation of a Web-Based Prognostic Tool for Predicting Survival in Patients in Hospice Care Journal of Palliative Care. 3(29) : 140-146, 2013.
  • Wao, H.Mhaskar, R.Kumar, A.Miladinovic, B.Djulbegovic, B. Survival of patients with non-small cell lung cancer without treatment: a systematic review and meta-analysis. Systematic reviews. 2: 10, 2013. http://www.ncbi.nlm.nih.gov/pubmed/23379753
  • August, EM; Dickerson, S; Scian, J; Dimaggio, A ; Sultan, D; Mhaskar, R ; Rivers, BM FORMATIVE EVALUATION OF A VIDEO-BASED PATIENT DECISION AID FOR PROSTATE CANCER AMONG AFRICAN AMERICAN MEN: IMPLICATIONS FOR MULTIMEDIA OUTREACH AND EDUCATION ANNALS OF BEHAVIORAL MEDICINE. 43: S222, 2012.
  • Kharfan-Dabaja, MA ; Mhaskar, R ; Pidala, JA ; Perkins, JB ; Djulbegovic, B; Kumar, A COMPARISON OF MYCOPHENOLATE MOFETIL (MMF) VERSUS METHOTREXATE (MTX) FOR PREVENTION OF ACUTE GRAFT-VERSUS-HOST DISEASE: RESULTS OF A META-ANALYSIS Biology of Blood and Marrow Transplantation. 18(2) : S358-S359, 2012.
  • Mahony, Helen; Tsalatsanis, Athanasios; Mhaskar, Rahul; et al. Social Network Analysis (SNA) of Salvage Therapies in Multiple Myeloma (MM) BLOOD. 120(21) : 4239, 2012.
  • Kumar, A.Mhaskar, AR.Reljic, T.Mhaskar, RS.Kharfan-Dabaja, MA.Anasetti, C.Mohty, M.Djulbegovic, B. Antithymocyte globulin for acute-graft-versus-host-disease prophylaxis in patients undergoing allogeneic hematopoietic cell transplantation: a systematic review. Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K. 26(4) : 582-8, 2012. http://www.ncbi.nlm.nih.gov/pubmed/22182922
  • Mhaskar, R.Djulbegovic, B.Magazin, A.Soares, HP.Kumar, A. Published methodological quality of randomized controlled trials does not reflect the actual quality assessed in protocols. Journal of clinical epidemiology. 65(6) : 602-9, 2012. http://www.ncbi.nlm.nih.gov/pubmed/22424985
  • Mhaskar, R.Redzepovic, J.Wheatley, K.Clark, OA.Miladinovic, B.Glasmacher, A.Kumar, A.Djulbegovic, B. Bisphosphonates in multiple myeloma: a network meta-analysis. Cochrane database of systematic reviews (Online). 5: CD003188, 2012. http://www.ncbi.nlm.nih.gov/pubmed/22592688
  • Miladinovic, B.Kumar, A.Mhaskar, R.Kim, S.Schonwetter, R.Djulbegovic, B. A flexible alternative to the Cox proportional hazards model for assessing the prognostic accuracy of hospice patient survival. PloS one. 7(10) : e47804, 2012. http://www.ncbi.nlm.nih.gov/pubmed/23082220
  • Kharfan-Dabaja, Mohamed A.; Mhaskar, Rahul; Reljic, Tea; et al. Mycophenolate Mofetil versus Methotrexate for Prevention of Acute Graft-Versus-Host Disease: Results of a Systematic Review Limited to Prosepective Randomized Controlled Studies BLOOD. 120(21) : 4168, 2012.
  • Miladinovic, Branko; Kumar, Ambuj; Mhaskar, Rahul; et al. Trial Sequential Analysis in Meta-Analyses of Maintenance Therapies for Multiple Myeloma BLOOD. 120(21) : 2975, 2012.
  • Mahony, Helen; Kumar, Ambuj; Mhaskar, Rahul et al Maintenance Therapies for Multiple Myeloma (MM): A Network Meta-Analysis BLOOD. 120(21) : 236, 2012.
  • Mahony, Helen; Kumar, Ambuj; Mhaskar, Rahul et al Maintenance Therapies for Multiple Myeloma (MM): A Direct Meta-Analysis BLOOD. 120(21) : 4271, 2012.
  • Wilson, D. Dapic V. Mhaskar R. Miladinovic B. Kumar A. Kumar N. Connors S. Powsang J. Rivers B. Developing a systematic review analyzing chemoprevention using natural and/or synthetic agents for prostate cancer American institute for cancer research Annual research conference paper. , 2011.
  • Mhaskar, R.; Georgiev, H.; Wao, H.; et al. How often do decision analyses of interventions agree with matching systematic reviews? Cochrane Colloquim Paper. , 2011.
  • Mhaskar, R. Magazin A. Kumar A. Djulbegovic B. Impact of reported vs. actual methodological quality assessment on treatment effect size Cochrane Colloquim Paper. , 2011.
  • Mhaskar, R.; Georgiev, H.; Wao, H.; et al. Using data from systematic reviews or multiple sources in decision analyses impacts the conclusions Society Of Medical Decision Making Annual Conference paper. , 2011.
  • Benjamin Djulbegovic, Ambuj Kumar, Branko Miladinovic, Tea Reljic, Sanja Galeb, Asmita Mhaskar, Rahul Mhaskar, Dongsheng Tu, Heather Stanton, Iztok Hozo, Christopher Booth and Ralph Meyer Success in Meeting the Primary Endpoint in Phase III Trials: A Comparison of Industry and Cooperative Group Trials BLOOD. 118(21) : 237, 2011.
  • Mhaskar R, Miladinovic B, Tsalatsanis A, mbah A, Kumar A, Sehwan K, Schonwetter R, Djulbegovic B External Validation of Prognostic Models in Terminally Ill Patients BLOOD. (21) : 1791, 2011.
  • Mhaskar, R. Magazin A. Soares H. Kumar A. Djulbegovic B. True methodological quality of trials are not reflected in their reporting Cochrane Colloquim Paper. , 2011.
  • Mhaskar, R.Redzepovic, J.Wheatley, K.Clark, OA.Miladinovic, B.Glasmacher, A.Kumar, A.Djulbegovic, B. Bisphosphonates in multiple myeloma. Cochrane database of systematic reviews (Online). (3) : CD003188, 2011. http://www.ncbi.nlm.nih.gov/pubmed/20238320
  • Pathak, Y.; Mhaskar, R. Aging in India: A conflict between industrialization and changing cultural values American Public Health Association Annual Conference Paper. , 2011.
  • Mhaskar R, Wao H, Reljic T, Kumar A, Djulbegovic B Impact of National Cancer Institute's Common Toxicity Criteria and Common Terminology Criteria for Adverse Events on Quality of Treatment Related Harms Reporting: An Analysis of National Cancer Institute's Co-Operative Group Phase III Randomized Controlled Trials BLOOD. 118(21) : 309, 2011.
  • Mhaskar R, Wao H, Kumar A, Miladinovic B, Djulbegovic B Role of Iron Supplementation to Erythropoiesis Stimulating Agents In the Management of Chemotherapy-Induced Anemia In Cancer Patients: A Systematic Review and Meta-Analysis BLOOD. 116(21) : 853, 2010.
  • Mhaskar, R.Redzepovic, J.Wheatley, K.Clark, OA.Miladinovic, B.Glasmacher, A.Kumar, A.Djulbegovic, B. Comparative Effectiveness of Bisphoshonates In Multiple Myeloma. BLOOD. 116(21) : 1248, 2010.
  • Wager, E.Mhaskar, R.Warburton, S.Djulbegovic, B. JAMA published fewer industry-funded studies after introducing a requirement for independent statistical analysis. PloS one. 5(10) : e13591, 2010. http://www.ncbi.nlm.nih.gov/pubmed/21042585
  • Mhaskar, R.Kumar, A.Behera, M.Kharfan-Dabaja, MA.Djulbegovic, B. Role of high-dose chemotherapy and autologous hematopoietic cell transplantation in primary systemic amyloidosis: a systematic review. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 15(8) : 893-902, 2009. http://www.ncbi.nlm.nih.gov/pubmed/19589478
  • Mhaskar R, Kumar A, Soares H, Schell M, Djulbegovic B Does quality of treatment-related harms reporting affect conclusions about superiority of treatment? JOURNAL OF CLINICAL ONCOLOGY. 27(15) , 2009.
  • Mhaskar, R. S. Kumar A. Soares H. Gardner W. Djulbegovic B. Treatment related harms: What was planned and what was reported? An analysis of Southwest Oncology Group Phase III trials Cochrane Colloquim Paper. , 2009.
  • Mhaskar, R.Emmanuel, P.Mishra, S.Patel, S.Naik, E.Kumar, A. Critical appraisal skills are essential to informed decision-making. Indian journal of sexually transmitted diseases. 30(2) : 112-9, 2009. http://www.ncbi.nlm.nih.gov/pubmed/21938133
  • Kumar, A. Mhaskar, R Response: Re: High-Dose Chemotherapy with Autotransplantation in AL Amyloidosis: A Flawed Meta-analysis Biol Blood Marrow Transplant. 16(1) : 140-141, 2009.
  • Kumar, A.; List, A.; Mhaskar, R.; et al. Efficacy of Hypo-Methylating Agents in the Treatment of Myelodysplastic Syndromes: A Systematic Review and Meta-Analysis of Randomized Controlled Trials European Society of Hematology Congress Paper. , 2008.
  • Mhaskar, R.; Kumar, A.; Djulbegovic, B. Agreement of decision analyses and matching randomized clinical trials in assessment of treatment comparisons: a systematic review Society Of Medical Decision Making Annual Conference paper. , 2008.
  • Lobas J, Penziner A, Wallis A, Mhaskar A R, Mhaskar R S, Till L Health Care Utilization – Patient/Provider Education, Care Coordination, and Case Management. Iowa Department of Human Services. , 2006.

Awards/Honors

  • Thomas C Chalmers Award (Cochrane Collaboration - 2011)
  • Research scholarship (University of South Florida - 2009)
  • Klasko Fellowship (USF College of Public Health - 2006)
  • Mel and Enid Zuckerman College of Public Health Fellowship (The University of Arizona - 2005)
  • Excellence for best research presentation award (The University of Arizona - 2005)
  • Young investigator research award (YUMA Friends of Arizona Health Science Center - 2005)